AIQ
New York, US · Founded 2010 · 6 known investors
AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.
Founders & leadership
TG
T. Gary LibermanChief Financial Officer and Secretary
NW
Nicholas W. StullerChief Executive Officer
Board
WO
William O'ConorMember of the Board of Directors
Investors · 6
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2014
▶$1.5MraisedApr 2014 · 13 investors · Other TechnologyRule 506(b)
▶$1.5MraisedApr 2014 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William O'ConorDirector
- T. Gary LibermanExecutive Officer
- Nicholas W. StullerExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.5M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $881.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $388.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Meet the AIQ Talks speakers: Industry leaders bringing real-world AI insights to the TOI AI Quotient Awards 2026 | - The Times of Indiatimesofindia.indiatimes.com · Aug 2026Frequently asked questions
- What does AIQ do?
- AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.
- Who are AIQ's investors?
- AIQ's investors include Aurora Forge, Capital Midwest Fund, New York Angels, Rock River Capital Partners, Tundra Angels, Venture Management.
- How much funding has AIQ raised?
- AIQ has disclosed $1.5M raised across 1 round.
- Where is AIQ headquartered?
- AIQ is headquartered in New York, US.